Innogenetics NV is a Belgium-based international biopharmaceutical company founded in 1985. Innogenetics NV is an international biotechnological company that develops and markets diagnostic products to improve therapy management and patient health. Innogenetics develops and markets a wide range of diagnostic assays with a focus on molecular Diagnostics and multiparameter testing. Its products are sold in over 90 countries through its 6 subsidiaries and a large number of distributors. Innogenetics grouped its therapeutics activities into the wholly owned subsidiary, GENimmune.

Company was acquired by Solvay Pharmaceuticals

Acquired Companies: GENimmune NV